Latest ADAP reports update at 2024-05-15: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Adaptimmune Therapeutics plc ADAP

$ 1.13 11.88%

Adaptimmune Therapeutics plc Deferred Revenue 2011-2024 | ADAP

Annual Deferred Revenue Adaptimmune Therapeutics plc

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
29 M	23.5 M	22.2 M	2.83 M	2.13 M	-	38.7 M	11.4 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
38.7 M	2.13 M	18.5 M

Quarterly Deferred Revenue Adaptimmune Therapeutics plc

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
31.5 M	29 M	29.3 M	31.4 M	22.3 M	23.5 M	20.6 M	-	24.8 M	22.2 M	6.1 M	4.91 M	2.08 M	2.83 M	2.83 M	2.83 M	2.83 M	2.13 M	2.13 M	2.13 M	2.13 M	-	1.34 M	16.7 M	27.2 M	38.7 M	42.6 M	12.3 M	11.6 M	11.4 M	11.4 M	11.4 M	12.1 M	12.5 M	12.5 M	12.5 M	12.5 M	-	-	41.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
42.6 M	1.34 M	15.4 M